Loopa Logic named a finalist in DPHARM Idol Disrupt 2026
Co-founder and COO Steven Moreno represented Loopa among six finalists at the clinical research innovation competition in Boston.
Event date: September 16, 2026
Loopa Logic was one of six finalists in DPHARM Idol Disrupt 2026, the live pitch competition held during the 16th annual DPHARM conference. The conference took place September 15–16 at the Sheraton Boston Hotel. Co-founder and COO Steven Moreno presented on behalf of the company.
Each finalist had six minutes to present its approach to a clinical development challenge before judges representing pharmaceutical sponsors, healthcare organizations, patient advocates, and life science investors.
Loopa’s presentation focused on reviewing uploaded study documents against protocol, governance, and applicable regulatory requirements, and organizing potential issues for human assessment.
Within Loopa’s workflow, a Loop is a structured, evidence-linked item for a reviewer to assess. Issues confirmed through that review become findings. This connects document processing with the clinical judgment needed to determine what an issue means and how it should be followed up.